Paratek Pharmaceuticals I...

NASDAQ: PRTK · Real-Time Price · USD
2.23
0.04 (1.83%)
At close: Sep 20, 2023, 10:00 PM

Paratek Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-63.57M -59.08M
Depreciation & Amortization
490K 391K
Stock-Based Compensation
12.32M 14.34M
Other Working Capital
21.05M 22.33M
Other Non-Cash Items
5.41M 4.27M
Deferred Income Tax
n/a n/a
Change in Working Capital
-20.79M -8.19M
Operating Cash Flow
-66.14M -48.27M
Capital Expenditures
-36K -373K
Cash Acquisitions
n/a n/a
Purchase of Investments
-15.16M -15.12M
Sales Maturities Of Investments
30M 20M
Other Investing Acitivies
n/a n/a
Investing Cash Flow
14.8M 4.51M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
5.09M 18.33M
Financial Cash Flow
5.09M 18.33M
Net Cash Flow
-46.24M -25.43M
Free Cash Flow
-66.18M -48.65M